SERYNTH FAST RELIEF NASAL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SERYNTH FAST RELIEF NASAL
Generic name
NAPHAZOLINE HCL 0.05% FAST RELIEF NASAL
Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD
Product type
HUMAN OTC DRUG
SPL set ID
4a4abdc0-aded-1b8a-e063-6394a90a9b56
SPL ID
572991c4-c664-d0b7-e063-6394a90ae600
Version
2
Effective date
2026-07-21
Source export date
2026-10-27
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run
20261027T193451Z
Imported at
2026-10-27 20:15:43
Harmonized routes table
Harmonized routes
NASAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use if you have ·heart disease ·high blood pressure .thyroid disease ·diabetes ·trouble urinating due to enlarged prostate gland

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.